Ubs Group Ag Abvc Biopharma, Inc. Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.62 - $9.1 $2,650 - $38,902	4,275 New	4,275 $2,000
Q2 2022 Aug 10, 2022	SELL	$0.9 - $2.93 $1,146 - $3,732	-1,274 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.18 - $3.72 $13,921 - $23,755	-6,386 Reduced 83.37%	1,274 $3,000
Q4 2021 Feb 14, 2022	BUY	$2.15 - $6.03 $16,469 - $46,189	7,660 New	7,660 $26,000

Ticker ABVC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,632,300
Market Cap $22.8M
Description
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major dep...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.